↓ Skip to main content

Adjunctive therapy for severe malaria: a review and critical appraisal

Overview of attention for article published in Malaria Journal, January 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)

Mentioned by

twitter
37 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
169 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adjunctive therapy for severe malaria: a review and critical appraisal
Published in
Malaria Journal, January 2018
DOI 10.1186/s12936-018-2195-7
Pubmed ID
Authors

Rosauro Varo, Valerie M. Crowley, Antonio Sitoe, Lola Madrid, Lena Serghides, Kevin C. Kain, Quique Bassat

Abstract

Despite recent efforts and successes in reducing the malaria burden globally, this infection still accounts for an estimated 212 million clinical cases, 2 million severe malaria cases, and approximately 429,000 deaths annually. Even with the routine use of effective anti-malarial drugs, the case fatality rate for severe malaria remains unacceptably high, with cerebral malaria being one of the most life-threatening complications. Up to one-third of cerebral malaria survivors are left with long-term cognitive and neurological deficits. From a population point of view, the decrease of malaria transmission may jeopardize the development of naturally acquired immunity against the infection, leading to fewer total cases, but potentially an increase in severe cases. The pathophysiology of severe and cerebral malaria is not completely understood, but both parasite and host determinants contribute to its onset and outcomes. Adjunctive therapy, based on modulating the host response to infection, could help to improve the outcomes achieved with specific anti-malarial therapy. In the last decades, several interventions targeting different pathways have been tested. However, none of these strategies have demonstrated clear beneficial effects, and some have shown deleterious outcomes. This review aims to summarize evidence from clinical trials testing different adjunctive therapy for severe and cerebral malaria in humans. It also highlights some preclinical studies which have evaluated novel strategies and other candidate therapeutics that may be evaluated in future clinical trials.

Twitter Demographics

The data shown below were collected from the profiles of 37 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 169 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 169 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 33 20%
Researcher 25 15%
Student > Ph. D. Student 16 9%
Student > Bachelor 15 9%
Student > Postgraduate 12 7%
Other 25 15%
Unknown 43 25%
Readers by discipline Count As %
Medicine and Dentistry 36 21%
Agricultural and Biological Sciences 21 12%
Biochemistry, Genetics and Molecular Biology 18 11%
Immunology and Microbiology 15 9%
Neuroscience 4 2%
Other 21 12%
Unknown 54 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2019.
All research outputs
#957,944
of 17,834,976 outputs
Outputs from Malaria Journal
#165
of 4,872 outputs
Outputs of similar age
#29,599
of 376,638 outputs
Outputs of similar age from Malaria Journal
#1
of 1 outputs
Altmetric has tracked 17,834,976 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,872 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 376,638 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them